PortfoliosLab logo
MED vs. GPC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MED and GPC is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MED vs. GPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and Genuine Parts Company (GPC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MED:

-1.01

GPC:

-0.38

Sortino Ratio

MED:

-1.52

GPC:

-0.33

Omega Ratio

MED:

0.84

GPC:

0.95

Calmar Ratio

MED:

-0.47

GPC:

-0.35

Martin Ratio

MED:

-1.28

GPC:

-0.90

Ulcer Index

MED:

35.10%

GPC:

15.40%

Daily Std Dev

MED:

44.81%

GPC:

33.46%

Max Drawdown

MED:

-98.33%

GPC:

-54.89%

Current Drawdown

MED:

-95.43%

GPC:

-27.87%

Fundamentals

Market Cap

MED:

$147.83M

GPC:

$17.36B

EPS

MED:

-$0.64

GPC:

$6.09

PEG Ratio

MED:

1.95

GPC:

1.57

PS Ratio

MED:

0.27

GPC:

0.74

PB Ratio

MED:

0.69

GPC:

3.90

Total Revenue (TTM)

MED:

$543.45M

GPC:

$23.57B

Gross Profit (TTM)

MED:

$401.58M

GPC:

$8.52B

EBITDA (TTM)

MED:

$6.40M

GPC:

$1.65B

Returns By Period

In the year-to-date period, MED achieves a -23.67% return, which is significantly lower than GPC's 9.57% return. Over the past 10 years, MED has underperformed GPC with an annualized return of -5.91%, while GPC has yielded a comparatively higher 6.09% annualized return.


MED

YTD

-23.67%

1M

9.71%

6M

-26.50%

1Y

-45.17%

3Y*

-55.44%

5Y*

-29.80%

10Y*

-5.91%

GPC

YTD

9.57%

1M

10.39%

6M

5.12%

1Y

-12.55%

3Y*

1.96%

5Y*

13.55%

10Y*

6.09%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Medifast, Inc.

Genuine Parts Company

Risk-Adjusted Performance

MED vs. GPC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
The Risk-Adjusted Performance Rank of MED is 1111
Overall Rank
The Sharpe Ratio Rank of MED is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 66
Sortino Ratio Rank
The Omega Ratio Rank of MED is 99
Omega Ratio Rank
The Calmar Ratio Rank of MED is 2121
Calmar Ratio Rank
The Martin Ratio Rank of MED is 1515
Martin Ratio Rank

GPC
The Risk-Adjusted Performance Rank of GPC is 2828
Overall Rank
The Sharpe Ratio Rank of GPC is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of GPC is 2727
Sortino Ratio Rank
The Omega Ratio Rank of GPC is 2525
Omega Ratio Rank
The Calmar Ratio Rank of GPC is 3030
Calmar Ratio Rank
The Martin Ratio Rank of GPC is 3030
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MED vs. GPC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and Genuine Parts Company (GPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MED Sharpe Ratio is -1.01, which is lower than the GPC Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of MED and GPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

MED vs. GPC - Dividend Comparison

MED has not paid dividends to shareholders, while GPC's dividend yield for the trailing twelve months is around 3.18%.


TTM20242023202220212020201920182017201620152014
MED
Medifast, Inc.
0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%0.00%
GPC
Genuine Parts Company
3.18%3.43%2.74%2.06%2.33%3.15%2.87%3.00%2.84%2.75%2.86%2.16%

Drawdowns

MED vs. GPC - Drawdown Comparison

The maximum MED drawdown since its inception was -98.33%, which is greater than GPC's maximum drawdown of -54.89%. Use the drawdown chart below to compare losses from any high point for MED and GPC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MED vs. GPC - Volatility Comparison

Medifast, Inc. (MED) has a higher volatility of 11.48% compared to Genuine Parts Company (GPC) at 7.23%. This indicates that MED's price experiences larger fluctuations and is considered to be riskier than GPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MED vs. GPC - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and Genuine Parts Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B20212022202320242025
115.73M
5.87B
(MED) Total Revenue
(GPC) Total Revenue
Values in USD except per share items

MED vs. GPC - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and Genuine Parts Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
72.8%
37.1%
(MED) Gross Margin
(GPC) Gross Margin
MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported a gross profit of 84.25M and revenue of 115.73M. Therefore, the gross margin over that period was 72.8%.

GPC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Genuine Parts Company reported a gross profit of 2.17B and revenue of 5.87B. Therefore, the gross margin over that period was 37.1%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported an operating income of -1.26M and revenue of 115.73M, resulting in an operating margin of -1.1%.

GPC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Genuine Parts Company reported an operating income of 287.95M and revenue of 5.87B, resulting in an operating margin of 4.9%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medifast, Inc. reported a net income of -772.00K and revenue of 115.73M, resulting in a net margin of -0.7%.

GPC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Genuine Parts Company reported a net income of 194.39M and revenue of 5.87B, resulting in a net margin of 3.3%.